Effect of Abiomed BVS 5000 (Cardiovascular Inc., Danvers, MA, U.S.A) has been reported for mechanical assist circulation in cardiogenic shock. However, this pump is generally used as a ventricular assist device, not as a device for veno-arterial bypass. Therefore, we evaluated its effectiveness through an experiment. The left anterior descending branch of pigs' heart was ligated to prepare a model of acute myocardial infarction, and after the onset of cardiogenic shock, circulation was initially supported for 30 min using the BVS 5000, followed by support for another 30 min using a Gyro pump (Gyro, Kyocera, Inc., Kyoto, Japan). Subsequently, circulation was additionally supported for 30 min using both a Gyro and an intra-aortic balloon pump (IABP) (Tokai Medical Inc., Aichi, Japan) (Gyro + IABP). Circulation was supported in each group at 30-min intervals in the reversed order of assisted circulation. Although the mean aortic pressure, pump flow, and total flow were not significantly different among the three setups, the pulse pressure was 48.2 +/- 3.3, 12.2 +/- 2.2, and 29.9 +/- 3.8 mm Hg in Abiomed, Gyro, and Gyro + IABP, respectively. Although neither coronary arterial nor myocardial blood flow showed significant differences among the three setups, the renal arterial blood flow was significantly larger in BVS 5000 compared to the other two setups. In this study, we selected an alpha-cube (Platium Cube NCVC 6000, Edwards Research Medical Inc., Salt Lake City, UT, U.S.A.), which is considered as an oxygenator that produces minimum pressure loss. Therefore, the pulsatile flow we obtained with the Abiomed was maintained even after we started using the oxygenator. The pulsatile flow had positive effects on renal circulation and peripheral circulation.